Phenotypes associated with this allele
cellular
|
• primary mouse embryonic fibroblasts exposed to 4OHT for 5 days to activate cre/ERT2 recombinase exhibit decreased proliferation that is similar to that in single Kras mutants without further additive effects
|
normal phenotype
|
• 30 day old mice fed a tamoxifen diet for 3 months are healthy and show normal weight and activity and no obvious anatomical defects
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Braftm1Sva mutation
(1 available);
any
Braf mutation
(58 available)
Raf1tm2Bacc mutation
(0 available);
any
Raf1 mutation
(114 available)
|
|
|
nervous system
|
• cultured DRG neurons transfected with Cre-EGFP have very short axons, compared to long and dense axon networks formed by control neurons
|
cellular
|
• cultured DRG neurons transfected with Cre-EGFP have very short axons, compared to long and dense axon networks formed by control neurons
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Braftm1.1Sva mutation
(0 available);
any
Braf mutation
(58 available)
Braftm1Sva mutation
(1 available);
any
Braf mutation
(58 available)
Raf1tm1Bacc mutation
(0 available);
any
Raf1 mutation
(114 available)
Raf1tm2Bacc mutation
(0 available);
any
Raf1 mutation
(114 available)
Tg(Nes-cre)1Kln mutation
(4 available)
|
|
|
mortality/aging
|
• no double conditional embryos are found live at E14-15, but can be isolated at E13
|
nervous system
|
• DRG neurons cultured with NGF for 5 days show impaired axon outgrowth
|
|
• sensory nerve trunks form normally, but distal arborization is reduced compared to controls
|
|
• at E13, Ret levels in DRGs are reduced
|
cellular
|
• DRG neurons cultured with NGF for 5 days show impaired axon outgrowth
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Braftm1Sva mutation
(1 available);
any
Braf mutation
(58 available)
Raf1tm2Bacc mutation
(0 available);
any
Raf1 mutation
(114 available)
Tg(Nes-cre)1Kln mutation
(4 available)
|
|
|
mortality/aging
|
• most die before weaning
|
growth/size/body
|
• mice are smaller in the postnatal period than Braf conditional knockouts
|
nervous system
|
• deficiency of terminal axonal projections of parvalbumin-positive neurons toward the lateral motor pools of the spinal cord is seen compared to controls
|
|
• proprioceptive axons enter spinal cord normally, but few progress beyond intermediate zone
|
|
• at P12, number of Ret+ neurons in DRG is reduced; numbers of CGRG+ neurons are increased
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Braftm1Sva mutation
(1 available);
any
Braf mutation
(58 available)
Raf1tm2Bacc mutation
(0 available);
any
Raf1 mutation
(114 available)
Tg(Nes-cre)1Kln mutation
(4 available)
|
|
|
normal phenotype
|
• mice show no phenotypic abnormalities at any stage
|
mortality/aging
|
• although born alive death occurs around 21 days of age from aggressive neurodegenerative disease
|
growth/size/body
|
• after being born alive, pups show progressive growth retardation
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Braftm1Sva mutation
(1 available);
any
Braf mutation
(58 available)
Tg(Tek-cre/ERT2)1Arnd mutation
(1 available)
|
|
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Braftm1Sva mutation
(1 available);
any
Braf mutation
(58 available)
Tg(Camk2a-cre)1557Sva mutation
(0 available)
|
|
|
behavior/neurological
|
• six month old mice have poor context discrimination although contextual conditioning is normal
|
|
• six month old mice much slower to learn the platform position in a hidden platform Morris water maze (Motor coordination normal)
|
nervous system
|
• six month old mice are deficient in the early phase of long term potentiation although there is no disruption of synaptic transmission or presynaptic plasticity
|
mortality/aging
|
• following intratracheal instillation of adenovirus expressing Cre-recombinase (Ad-Cre), mice show 50% survival at 41.5 weeks compared to 40 weeks in single Kras heterozygous controls, indicating similar survival
|
neoplasm
|
• mice develop non-small cell lung carcinoma following intratracheal instillation of adenovirus expressing Cre-recombinase (Ad-Cre); tumor burden in similar to that seen in single Kras heterozygotes
|
respiratory system
|
• mice develop non-small cell lung carcinoma following intratracheal instillation of adenovirus expressing Cre-recombinase (Ad-Cre); tumor burden in similar to that seen in single Kras heterozygotes
|
cellular
|
• primary mouse embryonic fibroblasts exposed to 4OHT for 5 days to activate cre/ERT2 recombinase exhibit decreased proliferation compared to single Kras heterozygotes
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Braftm1.1Sva mutation
(0 available);
any
Braf mutation
(58 available)
Braftm1Sva mutation
(1 available);
any
Braf mutation
(58 available)
Tg(Nes-cre)1Kln mutation
(4 available)
|
|
|
mortality/aging
|
• mice tend to die in third week postnatal, although some survive to P35
|
growth/size/body
|
• at P32, body weight is ~25% of littermates
|
|
• from P12-14 onwards, mice show severe growth retardation
|
behavior/neurological
N |
• mice show normal nociceptive response in hotplate assay
|
|
• mice appear hyperactive
|
nervous system
N |
• dorsal root ganglion neurons survive in mutants
|
|
• perivascular hypothalamic axonal innervation is reduced
|
|
• anterior lobe of pituitary gland is markedly reduced in size compared to controls
|
|
• disproportionate thinning of cortex is observed
|
endocrine/exocrine glands
|
• perivascular hypothalamic axonal innervation is reduced
|
|
• anterior lobe of pituitary gland is markedly reduced in size compared to controls
|
homeostasis/metabolism